Corteva, Inc. (NYSE:CTVA) Shares Sold by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. reduced its stake in shares of Corteva, Inc. (NYSE:CTVA) by 41.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,091 shares of the company’s stock after selling 1,485 shares during the quarter. Geneos Wealth Management Inc.’s holdings in Corteva were worth $100,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC acquired a new position in Corteva during the second quarter worth about $28,000. CVA Family Office LLC acquired a new stake in shares of Corteva in the fourth quarter valued at approximately $25,000. PCA Investment Advisory Services Inc. acquired a new stake in shares of Corteva in the second quarter valued at approximately $31,000. NewSquare Capital LLC grew its position in shares of Corteva by 70.6% in the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after purchasing an additional 226 shares during the last quarter. Finally, Glass Jacobson Investment Advisors llc grew its position in shares of Corteva by 234.3% in the third quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock valued at $28,000 after purchasing an additional 389 shares during the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Performance

Shares of CTVA stock opened at $53.67 on Tuesday. The company’s fifty day simple moving average is $55.17 and its 200-day simple moving average is $50.20. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $63.06. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09. The company has a market cap of $37.51 billion, a PE ratio of 52.62, a P/E/G ratio of 1.40 and a beta of 0.77.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, February 1st. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The business had revenue of $3.71 billion for the quarter, compared to the consensus estimate of $3.54 billion. During the same quarter last year, the firm posted $0.16 EPS. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.86 EPS for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Friday, March 1st were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date was Thursday, February 29th. Corteva’s dividend payout ratio is presently 62.75%.

Analysts Set New Price Targets

Several analysts have recently commented on CTVA shares. Mizuho lowered their price target on shares of Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a research report on Thursday, February 1st. Wolfe Research began coverage on shares of Corteva in a research report on Friday, March 1st. They issued an “outperform” rating and a $67.00 price target on the stock. BNP Paribas upgraded shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 target price on the stock in a research report on Friday, February 2nd. JPMorgan Chase & Co. restated a “neutral” rating and set a $57.00 target price (down previously from $58.00) on shares of Corteva in a research report on Friday. Finally, Oppenheimer raised their target price on shares of Corteva from $60.00 to $62.00 and gave the stock an “outperform” rating in a research report on Friday, February 2nd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $63.05.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.